Tolerance Assessment of Tailored 3d-printed TFO With Silicone Interface for the Treatment of Post-burn Face Scar
NCT ID: NCT04884789
Last Updated: 2025-03-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2025-01-01
2028-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Differential Pressure Distribution Orthosis by 3D Printing Process in the Treatment of Post-burn Hypertrophic Scarring
NCT06487910
Study of Silicone Material Inserts To Treat Burn Scars
NCT03159182
Evaluation of the Product Properties of Individualized 3D-compression Garments to Treat Scars
NCT03664505
Hypertrophic Scarring After Facial Burn
NCT00242970
Fractional Ablative Laser Treatment for Skin Grafts
NCT04176705
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Hypertrophic scars (HS) are frequent consequences of dermal burn with a prevalence of 70% of burned people. HS, which are a dermal fibro-proliferation, are rigid, erythematous and thickened scars associated with pigmentation abnormalities, xerosis, thermal sensitivity, pain and pruritus.
When HS is located on the face, they can cause cosmetic disorder with disfigurement and psychological distress.
Pressure therapy and silicone application are the two recommended non-invasive care for prevention and treatment of hypertrophic scarring after burn. On the face, Pressure Garment Therapy (PGT) cannot exert the required pressure because of concave or flat shape so the use of face mask is the most common form of pressure therapy on the face.
The face mask manufacturing is artisanal, time consuming and variable between all burn centers. They are not very accurate and have difficulties to apply effective pressure on certain face areas such as nasolabial folds.
Our Transparent Face Orthosis (TFO) uses tri-dimensional cam for measurement and 3d-printing technology for manufacturing. We think this way to manufacture the TFO will be more accurate and efficient, less expansive and time consuming. Moreover, the addition of a silicone interface between the TFO and the face will associate silicone application therapy and pressure therapy what should be more effective than pressure therapy alone.
The purpose of this study is to assess the tolerance of tailored 3d-printed transparent face orthosis used in the medical care of post-burn face scar.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DEVICE_FEASIBILITY
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Post-Burn Face scar
Use of 3d printed TFO with silicone interface (COFIS 3D)
COFIS 3D
Patient have to wear the COFIS 3D 20h a day for at least 6 month
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
COFIS 3D
Patient have to wear the COFIS 3D 20h a day for at least 6 month
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Post-Burn Face scar during maturation stage or surgical intervention on post-burn face scar during maturation stage
* Patient agrees to shave beard if necessary for 3D camera measurement
* Patient able to express informed consent
* Affiliation to a social security scheme
Exclusion Criteria
* Patient with unbalanced photosensitive epilepsy
* Patient with an unconsolidated fracture of the face's bones or skull
* Patient with a known allergy to silicone
* Pregnant or lactating women
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Régional Metz-Thionville
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Clémence DEFFINIS, MD
Role: PRINCIPAL_INVESTIGATOR
CHR Metz Thionville
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018-A03067-48
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.